entertainment -WSS

entertainment

author：focus 2025-09-02 08:21:36 - browse：5955

Andrew Trister, an oncologist and veteran of big technology companies and research, is Verily's new chief scientific officer.

As Verily aims to get on track, the Alphabet life science company has hired Andrew Trister, an oncologist and veteran of big technology companies and research, as its new chief scientific officer.

Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. He will also consult across Verily’s diverse projects.

Trister’s focus on public health will build on his recent role as a deputy director at the Bill and Melinda Gates Foundation, where he led digital health, including a project to build tech infrastructure to help with malaria testing. Trister also led the foundation’s Covid-19 response. In 2016, he was an early health hire at Apple. There, he worked on programs like a heart health study with Janssen, an app to promote healthy habits with Aetna, and research into digital biomarkers for Alzheimer’s disease with Eli Lilly and Evidation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: Amylyx, Aurinia, and IQVIA

explore

WSS

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Cholera vaccine supplies dangerously low, outbreaks surging

Long Covid research funding gets a major boost from NIH

Elisabeth Bik tackles the widespread issue of research misconduct

Medicare Advantage isn’t working — for anyone

Neuroscience renaissance leads to new crop of psychiatric drugs

hotspot

entertainment

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Using force crossed my mind when examining a defiant young patient

Novavax promises a turnaround & Lilly roils the obesity market

Cholera vaccine supplies dangerously low, outbreaks surging

Hollywood unions extend contract negotiations for actors

Elisabeth Bik tackles the widespread issue of research misconduct

Cancer drug shortages should be causing more outrage

Eli Lilly reports tirzepatide MASH success during Q4 earnings

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Change Healthcare cyberattack shows risk of industry consolidation

leisure time

Color Health wants to make cancer screenings convenient

Elisabeth Bik tackles the widespread issue of research misconduct

NEJM study measures Covid brain fog, impact on IQ

Tome Biosciences co

CDC panel: People 65 and older should get a Covid spring booster shot

Medicare isn't yet testing food as medicine

explore

leisure time

focus

leisure time